All Curated Mutation Sites in CHIKV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in CHIKV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
6K
  
C
  
E1
  
E2
  
E3
  
nsP1
  
nsP2
  
nsP3
  
nsP4
  
Pol
  

Keyword: Chikungunya Fever-26611825
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 26611825 A226V
E1
E1
Chikungunya Fever
R
L
View
2 26611825 A66V
E1
E1
Chikungunya Fever
R
View
3 26611825 S295P
E1
E1
Chikungunya Fever
R
View
4 26611825 V4A
E1
E1
Chikungunya Fever
R
View
5 26611825 Y93H
E1
E1
Chikungunya Fever
R
View
6 26611825 G82R
E2
E2
Chikungunya Fever
R
View
7 26611825 H18P
E2
E2
Chikungunya Fever
R
View
8 26611825 I377T
E2
E2
Chikungunya Fever
R
View
9 26611825 K211E
E1
E1
Chikungunya Fever
R
View
10 26611825 K252H
E2
E2
Chikungunya Fever
R
View
11 26611825 K252Q
E2
E2
Chikungunya Fever
R
View
12 26611825 K252QH
E2
E2
Chikungunya Fever
R
View
13 26611825 L210Q
E2
E2
Chikungunya Fever
R
View
14 26611825 L357Q
E2
E2
Chikungunya Fever
R
View
15 26611825 M390V
E2
E2
Chikungunya Fever
R
View
16 26611825 N245S
E2
E2
Chikungunya Fever
R
View
17 26611825 N72S
E2
E2
Chikungunya Fever
R
View
18 26611825 V264A
E2
E2
Chikungunya Fever
R
View
19 26611825 V291I
E1
E1
Chikungunya Fever
R
View
20 26611825 R171Q
nsP1
nsP1
Chikungunya Fever
R
View
21 26611825 I539S
nsP2
nsP2
Chikungunya Fever
R
View
22 26611825 N409T
nsP3
nsP3
Chikungunya Fever
R
View
Contents
Description

The table shows all curated mutation sites of CHIKV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.